Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -292.6% | -174.8% | 1 / 3 | -3.8% | -0.88 pp | -4.60 pp | -2.2% | 0.61 | — | 258 | −3,8% | −7,0 | −237,1% | — | 9.87 | — |
| Pts | 0 | 0 | 4 | 0 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.180 (close price on 2026-10-19)EPS (TTM): −259,8
Financial charts
1.Revenue & growth
VND bn258Q2/26
1.Revenue & growth
VND bn258Q2/26
2.Profit & growth
VND bn-8,01Q2/26
3.Profit mix (Penman)
VND bn-6,14Q2/26
4.Margins & cost structure
%5.4%Q2/26
5.Returns & cash cycle
% · days0.7%Q2/26
6.Earnings quality & cash
VND bn112Q2/26
7.Asset structure
VND bn1.128Q2/26
8.Funding & debt health
VND bn · times1.128Q2/26
9.Revenue backlog
VND bn22,5Q2/26
10.Valuation
times · %-16,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-196Q2/26
Adjusted EPS growth, latest quarter
-311%
Average adjusted EPS growth, 3 quarters
-150%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26